Squarepoint’s GeoVax Labs GOVX Stock Holding History

Squarepoint’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-31	Closed	-$51K	–	3297
2021 Q3	$51K	Buy	+31	New	+$54K	﹤0.01%	2768
2021 Q2	–	Sell	-28	Closed	-$46K	–	3409
2021 Q1	$46K	Buy	+28	New	+$54.5K	﹤0.01%	2990

Other funds holding GOVX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Squarepoint's GOVX Position: Q4 2021 in Review

Squarepoint sold out of GeoVax Labs (GOVX) in Q4 2021, closing a stake of 31 shares — an estimated $51K sold.

Squarepoint first reported a position in GOVX in Q1 2021 and held it in 2 quarters. The position peaked at $51K in Q3 2021. 13 funds tracked by Wall St. Rank hold GOVX as of Q4 2021.

Squarepoint reported no remaining GeoVax Labs position as of Q4 2021 after selling out during the quarter.
Squarepoint sold 31 GeoVax Labs shares in Q4 2021, an estimated $51K.
Squarepoint first reported a position in GeoVax Labs in Q1 2021 and held it in 2 quarters.
Squarepoint's GeoVax Labs position peaked at $51K in Q3 2021.
13 funds tracked by Wall St. Rank held GeoVax Labs as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.